Symbols

TRAK

ReposiTrak·NYSE

--(--)

TRAK fundamentals

TRAK Q2 2026 Earnings

ReposiTrak (TRAK) released its earnings on Feb 17, 2026: revenue was 5.86M (YoY +6.66%), beat estimates; EPS was 0.09 (YoY +12.50%), met estimates.

Revenue / YoY

5.86M

+6.66%

EPS / YoY

0.09

+12.50%

Report date

Feb 17, 2026

TRAK Earnings Call Summary for Q2,2026

Revenue Growth & Cash Flow: 7% revenue growth to $5.9M, net cash up 16% CAGR to $28.7M. Returned $2.2M to shareholders via buybacks.
AI-Driven Traceability: 500+ anomaly detection algorithms auto-correct 90% of supplier errors, reducing customer costs by 50%.
FDA Deadline Catalyst: 18-month countdown to 2028 compliance, with 70% of suppliers unprepared. Company expects Q4 2026 onboarding surge.
Cross-Selling Success: 98% recurring revenue mix, cross-sell rate up 30% YoY across compliance, supply chain, and Traceability solutions.
Patent Moat: 9 issued patents + 2 new filings protect Touchless Traceability IP, blocking competitors from copying core innovations.

Earnings

EPS

Revenue

Revenue & Expenses

TRAK has released its 2026 Q2 earnings report, with revenue of 5.86M, reflecting a YoY change of 6.66%, and net profit of 1.69M, showing a YoY change of 8.70%. The Sankey diagram below clearly presents TRAK's revenue sources and cost distribution.

Key Indicators

ReposiTrak (TRAK) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

ReposiTrak (TRAK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

ReposiTrak (TRAK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

ReposiTrak (TRAK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown